Immunic
IMUX
59 hedge funds and large institutions have $37.6M invested in Immunic in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 10 closing their positions.
958% more call options, than puts
Call options by funds: $582K | Put options by funds: $55K
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
8% more capital invested
Capital invested by funds: $35M → $37.6M (+$2.63M)
7% more funds holding
Funds holding: 55 → 59 (+4)
0.91% less ownership
Funds ownership: 5.24% → 4.33% (-0.91%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$472K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$426K |
| 3 |
Millennium Management
New York
|
+$377K |
| 4 |
Squarepoint
New York
|
+$240K |
| 5 |
Renaissance Technologies
New York
|
+$229K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$5.04M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$1.25M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$808K |
| 4 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$582K |
| 5 |
Morgan Stanley
New York
|
-$463K |
IMUX Hedge Fund Activity: Q3 2025 in Review
59 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2025, worth a combined $37.6M — up 7.5% from $35M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IMUX positions and 10 closed out — a net gain of 4 holders — while 10 added to existing stakes and 9 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $472K. The largest seller was Soleus Capital Management, cutting an estimated $5.04M.
- 59 institutional investors held Immunic (IMUX) as of Q3 2025, up from 55 in Q2 2025.
- Funds reported $37.6M of Immunic stock for Q3 2025, up 7.5% quarter-over-quarter.
- 14 funds opened new Immunic positions in Q3 2025 and 10 closed out, a net change of +4 holders.
- The largest Immunic buyer in Q3 2025 was Citadel Advisors, an estimated $472K added.
- The largest Immunic seller in Q3 2025 was Soleus Capital Management, an estimated $5.04M sold.
Based on aggregated 13F filings for Q3 2025.